Our data unveiled that GLI1 repression reversed METTL3/14/IGF2BP2 overexpression-induced proliferative advantage of lung cancer stem-like cells, suggesting its pivotal role in the whole network. This evidence concerns the gene IGF2BP2 and lung carcinoma.